Effects of intraperitoneal hyaluronan on peritoneal fluid and solute transport in peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 23, Issue 1, 2003, Pages 63-73

  Moberly, James B ^a   Sorkin, Michael ^a   Kucharski, Andrew ^a   Ogle, Kristen ^a   Mongoven, James ^a   Skoufos, Line ^a   Lin, Lawrence ^a   Bailey, Susan ^b   Rodela, Helen ^b   Mupas, Lou ^b   Walele, Aziz ^b   Ogrinc, Francis ^a   White, Darci ^a   Wolfson, Marsha ^a   Martis, Leo ^a   Breborowicz, Andrzej ^c   Oreopoulos, Dimitrios G ^b  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Glycosaminoglycan; Hyaluronic acid; Peritoneal membrane

Indexed keywords

ALBUMIN; CREATININE; DIALYSIS FLUID; DIANEAL; GLUCOSE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; PERITONEAL DIALYSIS FLUID; RADIOIODINATED HUMAN SERUM ALBUMIN; SODIUM; UREA;

ADULT; AGED; ARTICLE; CLEARANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSATE; FEMALE; HUMAN; MALE; PERITONEAL DIALYSIS; PERITONEAL FLUID; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAFETY; SAMPLE SIZE; SOLUTE; STATISTICAL SIGNIFICANCE; ULTRAFILTRATION;

EID: 12244311944     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080302300109     Document Type: Article

References (35)

1. Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992; 6:2397-404.
2. Laurent TC, Laurent UB, Fraser JR. The structure and function of hyaluronan: an overview. Immunol Cell Biol 1996; 74:A1-A7.
3. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997; 242:27-33.
4. Scott JE, Cummings C, Brass A, Chen Y. Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowing-electron microscopy and computer simulation. Hyaluronan is a very efficient network-forming polymer. Biochem J 1991; 274:699-705.
5. Ohashi Y, Honda A, Iwai T, Mori Y. Stimulatory effect of vanadate on hyaluronic acid synthesis in mesothelial cells from rabbit pericardium. Biochem Int 1988; 16:293-302.
6. Yung S, Coles GA, Williams JD, Davies M. The source and possible significance of hyaluronan in the peritoneal cavity. Kidney Int 1994; 46:527-33.
7. Breborowicz A, Korybalska K, Grzybowski A, Wieczorowska-Tobis K, Martis L, Oreopoulos DG. Synthesis of hyaluronic acid by human peritoneal mesothelial cells: effect of cytokines and dialysate. Perit Dial Int 1996; 16:374-8.
8. Breborowicz A, Wisniewska J, Polubinska A, Wieczorowska-Tobis K, Martis L, Oreopoulos DG. Role of peritoneal mesothelial cells and fibroblasts in the synthesis of hyaluronan during peritoneal dialysis. Perit Dial Int 1998; 18:382-6.
9. Yung S, Coles GA, Davies M. IL-1β, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD. Kidney Int 1996; 50:1337-43.
10. Honkanen E, Fröseth B, Grönhagen-Riska C. Serum hyaluronic acid and procollagen III amino terminal propeptide in chronic renal failure. Am J Nephrol 1991; 11:201-6.
11. Lai KN, Szeto CC, Lai KB, Lam CW, Chan DT, Leung JC. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD. Am J Kidney Dis 1999; 33:318-24.
12. Yamagata K, Tomida C, Koyama A. Intraperitoneal hyaluronan production in stable continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999; 19:131-7.
13. Polubinska A, Pawlaczyk K, Kuzlan-Pawlaczyk M, Wieczorowska-Tobis K, Chen C, Moberly JB, et al. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats. Kidney Int 2000; 57:1182-9.
14. Wang T, Chen C, Heimbürger O, Waniewski J, Bergström J, Lindholm B. Hyaluronan decreases peritoneal fluid absorption in peritoneal dialysis. J Am Soc Nephrol 1997; 8:1915-20.
15. Wang T, Cheng HH, Heimbürger O, Chen C, Waniewski J, Bergström J, et al. Hyaluronan decreases peritoneal fluid absorption: effect of molecular weight and concentration of hyaluronan. Kidney Int 1999; 55:667-73.
16. Wang T, Cheng HH, Heimbürger O, Waniewski J, Bergström J, Lindholm B. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume. Kidney Int 1998; 53: 496-502.
17. Rosengren BI, Carlsson O, Rippe B. Hyaluronan and peritoneal ultrafiltration: a test of the "filter-cake" hypothesis. Am J Kidney Dis 2001; 37:1277-85.
18. Breborowicz A, Polubinska A, Moberly J, Ogle K, Martis L, Oreopoulos D. Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats. Am J Kidney Dis 2001; 37:594-600.
19. Wieczorowska K, Breborowicz A, Martis L, Oreopoulos DG. Protective effect of hyaluronic acid against peritoneal injury. Perit Dial Int 1995; 15:81-3.
20. Guo QY, Peng WX, Cheng HH, Ye RG, Lindholm B, Wang T. Hyaluronan preserves peritoneal membrane transport properties. Perit Dial Int 2001; 21:136-42.
21. Gerdin B, Hallgren R. Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Intern Med 1997; 242:49-55.
22. Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol 1986; 119:219-34.
23. Lindholm B, Heimbürger O, Waniewski J, Werynski A, Bergström J. Peritoneal ultrafiltration and fluid reabsorption during peritoneal dialysis. Nephrol Dial Transplant 1989; 4:805-13.
24. Heimbürger O, Waniewski J, Werynski A, Park MS, Lindholm B. Lymphatic absorption in CAPD patients with loss of ultrafiltration capacity. Blood Purif 1995; 13:327-39.
25. Popovich RP, Pyle WK, Moncrief JW. Kinetics of peritoneal transport. In: Nolph KD, ed. Peritoneal Dialysis. Boston: Martinus Nijhoff; 1981: 79-123.
26. Nakamura M, Hikida M, Nakano T. Concentration and molecular weight dependency of rabbit corneal epithelial wound healing on hyaluronan. Curr Eye Res 1992; 11:981-6.
27. Bragantini A, Cassini M, De Bastiani G, Perbellini A. Controlled single-blind trial of intra-articularly injected hyaluronic acid (Hyalgen) in osteo-arthritis of the knee. Clin Trials J 1987; 24:333-40.
28. Graf J, Neusel E, Schneider E, Niethard FU. Intra-articular treatment with hyaluronic acid in osteoarthritis of the knee joint: a controlled clinical trial versus mucopolysaccharide polysulfuric acid ester. Clin Exp Rheumatol 1993; 11:367-72.
29. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1993; 1:97-103.
30. Storr-Paulsen A, Larsen M. Long-term results of extracapsular cataract extraction with posterior chamber lens implantation: sodium hyaluronate 1% vs hydroxypropyl methylcellulose 2%. Acta Ophthalmol (Copenh) 1991; 69:766-9.
31. Cobo M, Beaty N. VITRAX (sodium hyaluronate) in anterior segment surgery: a review and clinical study summary. Adv Ther 1990; 7:51-60.
32. Fraser JR, Laurent TC, Engstrom-Laurent A, Laurent UG. Elimination of hyaluronic acid from the blood stream in the human. Clin Exp Pharmacol Physiol 1984; 11:17-25.
33. Heimbürger O, Waniewski J, Werynski A, Tranæus A, Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38:495-506.
34. Heimbürger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992; 41: 1320-32.
35. Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962; 51: 224-32.